Ocumension Therapeutics
HKEX:1477

Watchlist Manager
Ocumension Therapeutics Logo
Ocumension Therapeutics
HKEX:1477
Watchlist
Price: 8.26 HKD -1.67%
Market Cap: 6.7B HKD

Wall Street
Price Targets

Price Targets Summary
Ocumension Therapeutics

Wall Street analysts forecast Ocumension Therapeutics stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Ocumension Therapeutics is 10.72 HKD with a low forecast of 10.26 HKD and a high forecast of 11.4 HKD.

Lowest
Price Target
10.26 HKD
24% Upside
Average
Price Target
10.72 HKD
30% Upside
Highest
Price Target
11.4 HKD
38% Upside
Ocumension Therapeutics Competitors:
Price Targets
600276
Jiangsu Hengrui Pharmaceuticals Co Ltd
28% Upside
GTII
Green Thumb Industries Inc
108% Upside
AHEALTH
Apex Healthcare Bhd
10% Downside
ELAN
Elanco Animal Health Inc
18% Upside

Revenue
Forecast

Revenue Estimate
Ocumension Therapeutics

For the last 5 years the compound annual growth rate for Ocumension Therapeutics's revenue is 366%. The projected CAGR for the next 3 years is 56%.

366%
Past Growth
56%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Ocumension Therapeutics

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
11%
Average Beat

Net Income
Forecast

Net Income Estimate
Ocumension Therapeutics

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-19%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Ocumension Therapeutics's stock price target?
Price Target
10.72 HKD

According to Wall Street analysts, the average 1-year price target for Ocumension Therapeutics is 10.72 HKD with a low forecast of 10.26 HKD and a high forecast of 11.4 HKD.

What is Ocumension Therapeutics's Revenue forecast?
Projected CAGR
56%

For the last 5 years the compound annual growth rate for Ocumension Therapeutics's revenue is 366%. The projected CAGR for the next 3 years is 56%.

Back to Top